journal article·2015-10

Novel CD44 receptor targeting multifunctional “nano-eggs” based on double pH-sensitive nanoparticles for co-delivery of curcumin and paclitaxel to cancer cells and cancer stem cells

Daquan Chen, Guohua Wang, Weiguo Song, Qiang Zhang

Journal of Nanoparticle Research· Volume 17· Issue 10
Publisher page

Abstract

Most anticancer drugs cannot kill cancer stem cells (CSCs) effectively, which lead to the failure of anticancer chemotherapy, such as relapse and metastasis. In this study, we prepared a multifunctional oligosaccharides of hyaluronan (oHA) conjugates, oHA-histidine-menthone 1,2-glycerol ketal (oHM). The oHM conjugates possess pH-sensitive menthone 1,2-glycerol ketal (MGK) as hydrophobic moieties and oHA as the target of CD44 receptor. Anticancer drugs, curcumin(Cur) and paclitaxel(PTX), were loaded into oHM micelles via self-assembly. Then, oHM micelles were mineralized through controlled deposition of inorganic calcium and phosphate ions on the nanoparticular shell via a sequential addition method to fabricate the “nano-eggs.” The formed nano-eggs had a smaller size (120.6 ± 4.5 nm) than oHM micelles (158.6 ± 6.4 nm), indicating that mineralization made the appearance of compact nanoparticles. Interestingly, when the nano-eggs were put into the acidic conditions (pH 6.5), their outer shell(inorganic minerals) will be destroyed with the larger size, while the “nano-eggs” were stable under pH 7.4. For both nano-eggs and oHM micelles, the Cur and PTX were released in a sustained manner depending on the pH of the solution. However, the nano-eggs showed much lower released than the oHM micelles due to the dissolution of the inorganic minerals and pH-sensitive ketal at mildly acidic environments (pH 6.5). In vivo study, the nano-eggs could get to the tumor site more effectively than oHM micelles. CSCs were sorted by a side population assay from MDA-MB-231 breast cancer cell lines over-expressing CD44 receptors. Antitumor activity was also evaluated on MDA-MB-231 xenografts in nude mice. The antitumor efficacy indicated that nano-eggs with co-delivery of Cur and PTX produced the strongest antitumor efficacy, and nano-eggs showed strong activity against cancer stem cells. These double pH-sensitive nano-eggs may provide a promising strategy for drug delivery to both cancer cells and cancer stem cells.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. Akbari M, Tamayol A, Laforte V, Annabi N, Najafabadi AH, Khademhosseini A, Juncker D (2014) Composite Living Fibers for Creating Tissue Constructs Using Textile Techniques. Adv Funct Mater 24(26):4060–406710.1002/adfm.201303655 ↗
2. Bae YH, Yin H (2008) Stability issues of polymeric micelles. J Control Release 131:2–410.1016/j.jconrel.2008.06.015 ↗
3. Biswas CS, Sulu E, Hazer B (2015) Effect of the composition of methanol − water mixtures on tacticity of poly(N-ethylacrylamide) gel. J Appl Polym Sci 132:41668–4167810.1002/app.41668 ↗
4. Botchkina GI, Zuniga ES, Rowehl RH, Park R, Bhalla R, Bialkowska AB, Johnson F, Golub LM, Zhang Y, Ojima I, Shroyer KR (2013) Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24. PLoS One 8:e6988410.1371/journal.pone.0069884 ↗
5. Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, Shakibaei M (2014) Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT. PLoS One 9:e10751410.1371/journal.pone.0107514 ↗
6. Charpentier MS, Whipple RA, Vitolo MI, Boggs AE, Slovic J, Thompson KN, Bhandary L, Martin SS (2014) Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer Res 74:1250–126010.1158/0008-5472.CAN-13-1778 ↗
7. Chen D, Sun J (2015) In vitro and in vivo evaluation of PEG-conjugated ketal-based chitosan micelles as the pH-sensitive carriers. Polym Chem 6:998–100410.1039/C4PY01639D ↗
8. Chen D, Wang H (2014) Novel pH-Sensitive Biodegradable Polymeric Drug Delivery Systems Based on Ketal Polymers. J Nanosci Nanotechnol 14:983–98910.1166/jnn.2014.9190 ↗
9. Chen D, Sun J, Lian S, Liu Z, Sun K, Liu W, Wu Z, Zhang Q (2014a) Dual pH-responsive and CD44 receptor targeted multifunctional nanoparticles for anticancer intracellular delivery. J Nanopart Res 16:274310.1007/s11051-014-2743-1 ↗
10. Chen D, Lian S, Liu Z, Zhao F, Jiang Y, Gao M, Sun K, Liu W, Fu F (2014b) Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition. Drug Deliv 3:1–610.3109/10717544.2014.917130 ↗
11. Choi KY, Min KH, Yoon HY, Kim K, Park JH, Kwon IC, Choi K, Jeong SY (2011) PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials 32:1880–188910.1016/j.biomaterials.2010.11.010 ↗
12. Clevers H (2011) The cancer stem cell: premises, promises and challenges. Nat Med 17:313e910.1038/nm.2304 ↗
13. Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275e8410.1038/nrc1590 ↗
14. Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal DM, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, Petrylak DP, Benson MC, Silva JM, Cordon-Cardo C (2012) Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer Cell 22:373e8810.1016/j.ccr.2012.07.016 ↗
15. Ganta S, Amiji M (2009) Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm 6:928–93910.1021/mp800240j ↗
16. Ganta S, Devalapally H, Amiji M (2010) Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation. J Pharm Sci 99:4630–464110.1002/jps.22157 ↗
17. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak Novakovic G (2007) Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA 104:11298–1130310.1073/pnas.0703723104 ↗
18. Götte M, Yip GW (2006) Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66:10233–1023710.1158/0008-5472.CAN-06-1464 ↗
19. Haynes MT, Huang L (2014) Lipid-coated calcium phosphate nanoparticles for nonviral gene therapy. Adv Genet 88:205–22910.1016/B978-0-12-800148-6.00007-9 ↗
20. Hossain M, Banik NL, Ray SK (2012) Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells. Neurochem Int 61:1102–111310.1016/j.neuint.2012.08.002 ↗
21. Huang L, Liao M, Chen S, Demillo VG, Dupre SA, Zhu X, Publicover NG, Hunter KW Jr (2014) A polymer encapsulation approach to prepare zwitterion-like, biocompatible quantum dots with wide pH and ionic stability. J Nanopart Res 16(8):255510.1007/s11051-014-2555-3 ↗
22. Kim SK, Foote MB, Huang L (2013) Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles. Cancer Lett 334:311–31810.1016/j.canlet.2012.07.011 ↗
23. Kim SS, Rait A, Kim E, Pirollo KF, Nishida M, Farkas N, Dagata JA, Chang EH (2014) A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival. ACS Nano 8:5494e514
24. Lehár J, Krueger AS, Avery W, Heilbut AM, Johansen LM, Price ER, Rickles RJ, Short GF 3rd, Staunton JE, Jin X, Lee MS, Zimmermann GR, Borisy AA (2009) Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol 27:659e66
25. Li RJ, Ying X, Zhang Yan JuRJ, Wang XX, Yao HJ, Men Y, Tian W, Yu Y, Zhang L, Huang RJ, Lu WL (2011) All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells. J Control Release 49:281e91
26. MacDiarmid JA, Amaro-Mugridge NB, Madrid-Weiss J, Sedliarou I, Wetzel S, Kochar K, Brahmbhatt VN, Phillips L, Pattison ST, Petti C, Stillman B, Graham RM, Brahmbhatt H (2009) Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug. Nat Biotechnol 27:643e5110.1038/nbt.1547 ↗
27. Malanchi I, Santamaria-Martinez A, Susanto E, Peng H, Lehr HA, Delaloye JF, Huelsken J (2012) Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481:85e910.1038/nature10694 ↗
28. Morra M (2005) Engineering of biomaterials surfaces by hyaluronan. Biomacromolecules 6:1205–122310.1021/bm049346i ↗
29. Mottaghitalab F, Farokhi M, Shokrgozar MA, Atyabi F, Hosseinkhani H (2015) Silk fibroin nanoparticle as a novel drug delivery system. J Control Release 206:161–17610.1016/j.jconrel.2015.03.020 ↗
30. Mukherjee D, Leo BF, Royce SG, Porter AE, Ryan MP, Schwander S, Chung KF, Tetley TD, Zhang J, Georgopoulos PG (2014a) Modeling physicochemical interactions affecting in vitro cellular dosimetry of engineered nanomaterials: application to nanosilver. J Nanopart Res 16(10):261610.1007/s11051-014-2616-7 ↗
31. Mukherjee S, Mazumdar M, Chakraborty S, Manna A, Saha S, Khan P, Bhattacharjee P, Guha D, Adhikary A, Mukhjerjee S, Das T (2014b) Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/beta-catenin negative feedback loop. Stem Cell Res Ther 5:11610.1186/scrt506 ↗
32. Najafabadi AH, Abdouss M, Faghihi S (2014a) Preparation and characterization of PEGylated chitosan nanocapsules as a carrier for pharmaceutical application. J Nanopart Res 16:1–1410.1007/s11051-014-2312-7 ↗
33. Najafabadi AH, Abdouss M, Faghihi S (2014b) Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: Ibuprofen. Mater Sci Eng C 41:91–9910.1016/j.msec.2014.04.035 ↗
34. Najafabadi AH, Tamayol A, Annabi N, Ochoa M, Mostafalu P, Akbari M, Nikkhah M, Rahimi R, Dokmeci MR, Sonkusale S, Ziaie B, Khademhosseini A (2014c) Biodegradable nanofibrous polymeric substrates for generating elastic and flexible electronics. Adv Mater 26(33):5823–583010.1002/adma.201401537 ↗
35. Owen SC, Chan DPY, Shoichet MS (2012) Polymeric micelle stability. Nano Today 7:53–6510.1016/j.nantod.2012.01.002 ↗
36. Sanal T, Oruç O, Öztürk T, Hazer B (2015) Synthesis of pH- and thermo-responsive poly (ε-caprolactone-b-4-vinyl benzyl-g-dimethyl amino ethyl methacrylate) brush type graft copolymers via RAFT polymerization. J Polym Res 22(3):1–12
37. Schulte PA, Geraci CL, Murashov V, Kuempel ED, Zumwalde RD, Castranova V, Hoover MD, Hodson L, Martinez KF (2014) (2013) Occupational safety and health criteria for responsible development of nanotechnology. J Nanopart Res 16:215310.1007/s11051-013-2153-9 ↗
38. Shi C, Guo X, Qu Q, Tang Z, Wang Y, Zhou S (2014a) Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles. Biomaterials 35:8711–872210.1016/j.biomaterials.2014.06.036 ↗
39. Shi S, Shi K, Tan L, Qu Y, Shen G, Chu B, Zhang S, Su X, Li X, Wei Y, Qian Z (2014b) The use of cationic MPEGPCL-g-PEI micelles for co-delivery of Msurvivin T34A gene and doxorubicin. Biomaterials 35:4536e47
40. Sun TM, Du JZ, Yao YD, Mao CQ, Dou S, Huang SY, Zhang PZ, Leong KW, Song EW, Wang J (2011) Simultaneous delivery of siRNA and paclitaxel via a “two-in-one” micelleplex promotes synergistic tumor suppression. ACS Nano 5:1483e94
41. Tseng YC, Xu Z, Guley K, Yuan H, Huang L (2014) Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases. Biomaterials 35:4688–469810.1016/j.biomaterials.2014.02.030 ↗
42. Walczak AP, Hendriksen PJ, Woutersen RA, van der Zande M, Undas AK, Helsdingen R, van den Berg HH, Rietjens IM, Bouwmeester H (2015) Bioavailability and biodistribution of differently charged polystyrene nanoparticles upon oral exposure in rats. J Nanopart Res 17(5):23110.1007/s11051-015-3029-y ↗
43. Wang J, Yang G, Guo X, Tang Z, Zhong Z, Zhou S (2014) Redox-responsive polyanhydride micelles for cancer therapy. Biomaterials 35:3080–309010.1016/j.biomaterials.2013.12.025 ↗
44. Wei W, Lv PP, Chen XM, Yue ZG, Fu Q, Liu SY, Yue H, Ma GH (2013) Codelivery of mtert siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression. Biomaterials 34:3912e23
45. Yallapu MM, Khan S, Maher DM, Ebeling MC, Sundram V, Chauhan N, Ganju A, Balakrishna S, Gupta BK, Zafar N, Jaggi M, Chauhan SC (2014) Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer. Biomaterials 35:8635–864810.1016/j.biomaterials.2014.06.040 ↗
46. Yang C, Cao M, Liu H, He Y, Xu J, Du Y, Liu Y, Wang W, Cui L, Hu J, Gao F (2012) The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem 287:43094–43010710.1074/jbc.M112.349209 ↗
47. Yu FY, Yao H, Zhu PC, Zhang XQ, Pan QH, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E (2007) Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131:1109e2310.1016/j.cell.2007.10.054 ↗
48. Yu H, Mu H, Xiu L, Sun K, Liu W, Chen D (2013) A Novel Ketal-Based Chitosan as Nano-Vehicles for Potential pH-Sensitive Nanomedicine Delivery. Nanosci Nanotechnol Lett 5:1007–101110.1166/nnl.2013.1660 ↗
49. Yu Y, Zhang X, Qiu L (2014) The anti-tumor efficacy of curcumin when delivered by size/charge-changing multistage polymeric micelles based on amphiphilic poly(β-amino ester) derivates. Biomaterials 35:3467–347910.1016/j.biomaterials.2013.12.096 ↗
50. Zhao J, Riediker M (2014) Detecting the oxidative reactivity of nanoparticles: a new protocol for reducing artifacts. J Nanopart Res 16:249310.1007/s11051-014-2493-0 ↗
51. Zhao Y, Alakhova DY, Kabanov AV (2013) Can nanomedicines kill cancer stem cells? Adv Drug Deliv Rev 65:1763e83
52. Zhou L, Jiang Y, Yan T, Di G, Shen Z, Shao Z, Lu J (2010) The prognostic pole of cancer stem cells in breast cancer: a meta-analysis of published literatures. Breast Cancer Res Treat 122:795e80110.1007/s10549-010-0999-4 ↗